Common genetic variation of β1-and β2-adrenergic receptor and response to four classes of antihypertensive treatment

Pharmacogenetics and Genomics

Volumn 20, Issue 5, 2010, Pages 342-345

  Suonsyrjä, Timo ^a   Donner, Kati ^a   Hannila Handelberg, Tuula ^a   Fodstad, Heidi ^a   Kontula, Kimmo ^a   Hiltunen, Timo P ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

B2 adrenergic receptor; Bisoprolol; Drugs hypertension; Pharmacogenetics; Polymorphism; 1 adrenergic receptor

Indexed keywords

AMLODIPINE; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BISOPROLOL; HYDROCHLOROTHIAZIDE; LOSARTAN;

ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; DNA POLYMORPHISM; GENETIC VARIABILITY; HOMOZYGOTE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRIORITY JOURNAL; TREATMENT RESPONSE;

EID: 77951498126     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e328338e1b8     Document Type: Article

References (10)

1. Filigheddu F, Reid JE, Troffa C, PinnaParpaglia P, Argiolas G, Testa A, et al. Genetic polymorphisms of the beta-adrenergic system: association with essential hypertension and response to beta-blockade. Pharmacogenomics J 2004; 4:154-160. (Pubitemid 38786553)
2. O'Shaughnessy KM, Fu B, Dickerson C,Thurston D, Brown MJ. The gain-of-function G389R variant of the beta1-adrenoceptor does not influence blood pressure or heart rate response to beta-blockade in hypertensive subjects. Clin Sci (Lond) 2000; 99:233-238.
3. Johnson JA, Zineh I, Puckett BJ, McGorray SP, Yarandi HN, Pauly DF. Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol. Clin Pharmacol Ther 2003; 74:44-52. (Pubitemid 36776175)
4. Liu J, Liu ZQ, Tan ZR, Chen XP, Wang LS, Zhou G, et al. Gly389Arg polymorphism of beta1-adrenergic receptor is associated with the cardiovascular response to metoprolol. Clin Pharmacol Ther 2003; 74: 372-379. (Pubitemid 37222858)
5. Liu J, Liu ZQ, Yu BN, Xu FH, Mo W, Zhou G, et al. beta1-adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension. Clin Pharmacol Ther 2006; 80:23-32. (Pubitemid 43946840)
6. Sofowora GG, Dishy V, Muszkat M, Xie HG, Kim RB, Harris PA, et al. A common beta1-adrenergic receptor polymorphism (Arg389Gly) affects blood pressure response to beta-blockade. Clin Pharmacol Ther 2003; 73:366-371. (Pubitemid 36403596)
7. Karlsson J, Lind L, Hallberg P, Michaelsson K, Kurland L, Kahan T, et al. Beta1-adrenergic receptor gene polymorphisms and response to beta1-adrenergic receptor blockade in patients with essential hypertension. Clin Cardiol 2004; 27:347-350. (Pubitemid 38703089)
8. Mahesh Kumar KN, Ramu P, Rajan S, Shewade DG, Balachander J, Adithan C. Genetic polymorphisms of beta1 adrenergic receptor and their influence on the cardiovascular responses to metoprolol in a South Indian population. J Cardiovasc Pharmacol 2008; 52:459-466.
9. Hiltunen TP, Suonsyrja T, Hannila-Handelberg T, Paavonen KJ, Miettinen HE, Strandberg T, et al. Predictors of antihypertensive drug responses: initial data from a placebo-controlled, randomized, cross-over study with four antihypertensive drugs (The GENRES Study). Am J Hypertens 2007; 20:311-318. (Pubitemid 46299151)
10. Huang G, Xing H, Hao K, Peng S, Wu D, Guang W, et al. Beta2 adrenergic receptor gene Arg16Gly polymorphism is associated with therapeutic efficacy of benazepril on essential hypertension in Chinese. Clin Exp Hypertens 2004; 26:581-592. (Pubitemid 39445747)